MYCN and childhood neoplasm: Epigenetic changes are considered to be a fundamental hallmark of pediatric tumors including neuroblastoma39,40, and previous studies have shown that MYCN is able to interact with and recruit PRC2 to epigenetically suppress target genes, a process that appears to be essential for MYCN oncogenesis41–44.